Skip to main content

Life Sciences

Advances in life sciences create new and exciting business opportunities. The protection and enforcement of intellectual property rights is critical to making the most of those opportunities.

Bereskin & Parr’s Life Sciences practice group is comprised of professionals with diverse technical backgrounds and industry expertise, ensuring members stay at the forefront of trends in the ever-changing industry, and in the law that relates to it.

Our professionals hold graduate and doctoral degrees in immunology, organic and inorganic chemistry, biochemistry, molecular and human genetics and experimental medicine. This expert knowledge allows us to advise on and protect technology in all areas of life sciences including biotechnology, medical devices, pharmaceuticals, food science, materials, bio informatics, plants genetics and plant breeders’ rights. Our group applies a team approach to assist clients efficiently and effectively, utilizing the depth of background and expertise we have in the life sciences field.

Strong scientific backgrounds, along with the active participation in life sciences organizations and committees, allows the group to maintain an open and active dialogue with members of the scientific community. As developing and maintaining these relationships are of great value to the firm, our clients within universities, hospitals, research institutes, and Canadian and multinational biotechnology and pharmaceutical companies continuously keep us well-informed of their evolving businesses and legal needs.

The ability to find cost-effective solutions to our client’s needs, and the desire to ensure their matters are successfully accomplished, make us one of the strongest life sciences IP practices in Canada.

Our Services

The following is a list of services that members of our Life Sciences practice group provide:

  • Preparing and prosecuting patent applications worldwide
  • Preparing and negotiating licensing agreements
  • Conducting due diligence investigations
  • Providing patentability, validity, and infringement opinions
  • Providing strategic advice on intellectual property portfolios
  • Conducting intellectual property audits
  • Enforcing intellectual property rights

Our Life Sciences practice group has been recognized in several prominent national and international publications, including:

  • Chambers Global
  • Lexpert/American Lawyer Guide to the Leading 500 Lawyers in Canada
  • IAM Patent 1000 – The World’s Leading Patent Practitioners
  • The Canadian Legal Lexpert Directory

 

Recent Articles

Nearly 400-Year-Old English Statute of Monopolies Not Applicable to Damage Claim Under Canada’s Patented Drug Regime

Article
March 24, 2021

Nearly 400-Year-Old English Statute of Monopolies Not Applicable to Damage Claim Under Canada’s...

The Federal Court of Appeal Further Clarifies the Test for Obviousness: That Something is “Worth Trying” Does Not Mean That it was Obvious to Try

Article
March 16, 2021

The Federal Court of Appeal Further Clarifies the Test for Obviousness: That Something is “Worth...

Patenting Biologics and Other Therapeutics in the United States: Another Strike Against Claims with Functional Limitations

Article
March 11, 2021

Patenting Biologics and Other Therapeutics in the United States: Another Strike Against Claims...

Litigation Strategy Defines Large Cost Award in Pharma Patent Infringement Case

Article
March 10, 2021

Litigation Strategy Defines Large Cost Award in Pharma Patent Infringement Case

Valuing Patents: The Importance of a Patent Strategy for Business of all Sizes

Article
March 5, 2021

Valuing Patents: The Importance of a Patent Strategy for Business of all Sizes

Is there Magic in those Mushrooms? Part 2 – Protecting New Psilocybin Derivatives.

Article
March 1, 2021

Is there Magic in those Mushrooms? Part 2 – Protecting New Psilocybin Derivatives.

view more

Practice Group Leader

Micheline Gravelle Micheline Gravelle
B.Sc., M.Sc. (Immunology)
Partner
416.957.1682  email Micheline Gravelle
All Practice Group Members

  

Webinars

Is Canada on the Brink of an AI & Diagnostics Patent Rush?
Bereskin & Parr LLP
December 2, 2020, Online
The "W5" for patents - who can get one, what are they, where and when can you get one and why should you?
The Canadian Association of Research Administrators (CARA)
October 22, 2020, Online
IP Best Practices for Regional Innovation Centres
Spark Centre
October 16, 2020, Online

Speaking Engagements

CLIC Proposal Q&A Session
McGill Clinical Innovation Competition (CLIC)
March 19, 2021, Online
Update on Canadian Patent Law
Consero
December 7, 2020, Online
Gestion de l’innovation du Pr. Wadid Lamine
École de gestion Telfer – Université d’Ottawa
November 17, 2020

Events

2021 Canadian Region Meeting
AUTM
May 11 - 12, 2021, Online
Cannalaw Summit
Inside Practice
May 6, 2021, Online
Synapse Life Science Competition
Innovation Factory
March 24, 2021, Online
CTO2021 Clinical Trials Conference
Clinical Trials Ontario
March 23 - 25, 2021, Online
Effervescence 2021
Effervescence
March 15 - 17, 2021, Online